Last reviewed · How we verify
Pseudomembranous enterocolitis
Approved treatments
- Vancocin · ANI Pharmaceuticals
- Dificid · Cubist Pharms Llc
Dificid works by inhibiting protein synthesis in bacteria, preventing them from reproducing and causing infection.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pseudomembranous enterocolitis patent landscape — cliff calendar, originator estates, attackable patents
- Pseudomembranous enterocolitis treatment landscape brief
- Pseudomembranous enterocolitis treatment updates RSS
Frequently asked questions about Pseudomembranous enterocolitis
What drugs treat Pseudomembranous enterocolitis?
Tracked treatments include Vancocin, Dificid.
What is the treatment for Pseudomembranous enterocolitis?
Standard treatment for Pseudomembranous enterocolitis includes Vancocin, Dificid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pseudomembranous enterocolitis patent cliff · Pseudomembranous enterocolitis CI report
- Treatment: Vancocin · ANI Pharmaceuticals
- Treatment: Dificid · Cubist Pharms Llc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing